The Enterprise Value as of September 2024 (TTM) for bluebird bio, Inc. (BLUE) is 240.30M

According to bluebird bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 240.30M. This represents a change of -53.81% compared to the average of 520.26M of the last 4 quarters.

bluebird bio, Inc. (BLUE) Historical Enterprise Value (quarterly & annually)

How has BLUE Enterprise Value performed in the past?

The mean historical Enterprise Value of bluebird bio, Inc. over the last ten years is 1.73B. The current 240.30M Enterprise Value has changed 1.29% with respect to the historical average. Over the past ten years (40 quarters), BLUE's Enterprise Value was at its highest in in the March 2019 quarter at 5.59B. The Enterprise Value was at its lowest in in the December 2013 quarter at 119.07M.

bluebird bio, Inc. (BLUE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of bluebird bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

bluebird bio, Inc. (BLUE) Average Enterprise Value

How has BLUE Enterprise Value performed in the past?

The current Enterprise Value of bluebird bio, Inc. (BLUE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

bluebird bio, Inc. (BLUE) Enterprise Value vs. Peers

How is BLUE’s Enterprise Value compared to its peers?

bluebird bio, Inc.’s Enterprise Value is greater than Mersana Therapeutics, Inc. (138.92M), greater than Zentalis Pharmaceuticals, Inc. (217.53M), less than Y-mAbs Therapeutics, Inc. (539.42M), less than Travere Therapeutics, Inc. (1.21B), less than Madrigal Pharmaceuticals, Inc. (4.91B), less than Viking Therapeutics, Inc. (5.95B), less than Sarepta Therapeutics, Inc. (13.28B), greater than Hepion Pharmaceuticals, Inc. (2.24M), less than PTC Therapeutics, Inc. (2.17B), less than Agios Pharmaceuticals, Inc. (2.44B), less than Intercept Pharmaceuticals, Inc. (915.81M), greater than Karyopharm Therapeutics Inc. (201.87M), less than CureVac N.V. (0), less than Reata Pharmaceuticals, Inc. (390.67M), less than Krystal Biotech, Inc. (6.68B), less than Vir Biotechnology, Inc. (4.95B), less than Propanc Biopharma, Inc. (864.03M), greater than null (1.07M),

Build a custom stock screener for bluebird bio, Inc. (BLUE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like bluebird bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

bluebird bio, Inc. (BLUE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like bluebird bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.